Chinese drug packaging industry set to be worth RMB200 billion
Pharmaceutical packaging in China has increased at a rate of 10 percent in recent years and is predicted to continue high growth.
List view / Grid view
Pharmaceutical packaging in China has increased at a rate of 10 percent in recent years and is predicted to continue high growth.
The EU has issued two guidance documents intended to advise the pharmaceutical industry and patients during medicinal shortages.
The DHSC has announced their plans for pharmaceutical transportation in the case of a no-deal Brexit.
Three API re-packers who failed to meet current good manufacturing practice requirements have received warning letters from the FDA.
Substandard and counterfeit drugs can negatively impact the pharmaceutical industry and patients. Here, we investigate counterfeits in south-east Asia and possible solutions.
The MHRA has given marketing authorisation for short-term jet-lag therapy in adults.
The government has issued a letter to the pharmaceutical industry, outlining how to prepare for a no-deal Brexit.
Whether by ignorance of the latest best practices, or willful disregard for patient safety, the results of careless practice can often be fatal. The articles in this in-depth focus highlight how regulatory bodies are taking action to raise the industry’s game.
The FDA has announced its approval of a therapy for hypoactive sexual desire disorder in premenopausal women.
DHL Supply Chain is investing millions of dollars to expand its pharmaceutical and medical device distribution network in the US.
A multi-company system to improve traceability of pharmaceutical products is newly supported by the FDA.
In this issue we explore reasons behind critical key drug shortages in the EU, whether viability methods effectively detect all viable organisms and how companies can future-proof their digital technologies ahead of Brexit. Also included are articles on higher order protein structure, FMD compliance and Raman spectroscopy.
A data analyst has reported that the current US-China trade war will give India chance to increase their pharmaceutical presence.
Emirates SkyCargo has commenced handling pharmaceutical cargo at a new purpose-built facility in Chicago.
Decreased supply of anti-rabies vaccines (ARVs) in Delhi causes outbreak of the disease.